Candel Therapeutics, Inc. Common Stock (NASDAQ: CADL) last traded at $9.27, down 5.21% on the session. The quote above updates while this page is open; the figures below are drawn from Candel Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Candel Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker CADL. Its market capitalisation is $709.33 million.
Valuation measures for Candel Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $709.33M |
|---|---|
| Enterprise value | $589.78M |
| Price / book | 5.62 |
| Beta | 1.92 |
Trailing-twelve-month figures tagged in Candel Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$88.53M |
| EPS (TTM) | -$1.42 |
|---|
| Return on equity | -70.19% |
|---|
| Cash | $201.56M |
|---|
Range and volume for CADL over the past 52 weeks.
| 52-week high | $14.00 |
|---|---|
| 52-week low | $4.35 |
| Volume | 1.13M |
| Average volume | 1.19M |
| Previous close | $9.78 |
Invest a chosen dollar amount in Candel Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CADL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.